Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer-Reference-Cited by-同舟云学术

Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer

Published:2017-02 Issue:7642 Volume:542 Page:484-488
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Zhao Di,Lu Xin,Wang Guocan,Lan Zhengdao,Liao Wenting,Li Jun,Liang Xin,Chen Jasper Robin,Shah Sagar,Shang Xiaoying,Tang Ming,Deng Pingna,Dey Prasenjit,Chakravarti Deepavali,Chen Peiwen,Spring Denise J.,Navone Nora M.,Troncoso Patricia,Zhang Jianhua,Wang Y. Alan,DePinho Ronald A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature21357.pdf

Reference30 articles.

1. Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W. & Friend, S. H. Integrating genetic approaches into the discovery of anticancer drugs. Science 278, 1064–1068 (1997)

2. Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917–921 (2005)

3. Muller, F. L. et al. Passenger deletions generate therapeutic vulnerabilities in cancer. Nature 488, 337–342 (2012)

4. Cairns, P. et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res . 57, 4997–5000 (1997)

5. Wang, S. et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4, 209–221 (2003)

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNMT3A loss drives a HIF-1-dependent synthetic lethality to HDAC6 inhibition in non-small cell lung cancer;Acta Pharmaceutica Sinica B;2024-09

2. Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis;Scientific Reports;2024-08-15

3. Chromatin remodellers as therapeutic targets;Nature Reviews Drug Discovery;2024-07-16

4. Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology;Current Issues in Molecular Biology;2024-06-27

5. SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC;Advanced Science;2024-06-12